㈜에스비바이오사이언스

{
  "address": "경기도 수원시",
  "ceo_name": "염규호",
  "certificate": [
    {
      "cert_number": "20220331020073",
      "changes": "",
      "disclosure_date": "2022-03-31",
      "first_cert_date": "2022-03-30",
      "no": "1",
      "type": "연구개발유형",
      "valid_period": "2022-03-30 ~ 2025-03-29"
    },
    {
      "cert_number": "20250415010021",
      "changes": "",
      "disclosure_date": "2025-04-15",
      "first_cert_date": "2022-03-30",
      "no": "2",
      "type": "벤처투자유형",
      "valid_period": "2025-03-30 ~ 2028-03-29"
    }
  ],
  "company_name": "㈜에스비바이오사이언스",
  "corp_no": "200111-*******",
  "financials": {
    "2022": {
      "capital_stock": 65000000,
      "cost_of_sales": 0,
      "current_assets": 734637000,
      "current_liabilities": 298540000,
      "gross_profit": 15200000,
      "net_income": -176413000,
      "net_income_bs": -176413000,
      "non_current_assets": 146276000,
      "non_current_liabilities": 400000000,
      "non_operating_expenses": 6816000,
      "non_operating_income": 497026000,
      "operating_profit": -666623000,
      "revenue": 15200000,
      "sga_expenses": 681823000,
      "total_assets": 880913000,
      "total_equity": 182373000,
      "total_liabilities": 698540000
    },
    "2023": {
      "capital_stock": 65000000,
      "cost_of_sales": 0,
      "current_assets": 276527000,
      "current_liabilities": 72162000,
      "gross_profit": 45303000,
      "net_income": -175061000,
      "net_income_bs": -175061000,
      "non_current_assets": 302947000,
      "non_current_liabilities": 500000000,
      "non_operating_expenses": 13818000,
      "non_operating_income": 475297000,
      "operating_profit": -636540000,
      "revenue": 45303000,
      "sga_expenses": 681843000,
      "total_assets": 579474000,
      "total_equity": 7312000,
      "total_liabilities": 572162000
    },
    "2024": {
      "capital_stock": 65000000,
      "cost_of_sales": 5297000,
      "current_assets": 408137000,
      "current_liabilities": 137211000,
      "gross_profit": 220327000,
      "net_income": 57623000,
      "net_income_bs": 57623000,
      "non_current_assets": 294009000,
      "non_current_liabilities": 500000000,
      "non_operating_expenses": 18751000,
      "non_operating_income": 724407000,
      "operating_profit": -648033000,
      "revenue": 225624000,
      "sga_expenses": 868360000,
      "total_assets": 702146000,
      "total_equity": 64935000,
      "total_liabilities": 637211000
    }
  },
  "industry": "의학 및 약학 연구개발업",
  "investment": [
    {
      "amount": "100,020,000",
      "changes": "100,020,000",
      "date": "2021-01-22"
    }
  ],
  "main_products": "진단, 신약 기술 개발",
  "phone": "031-373-****",
  "years": [
    2024,
    2023,
    2022
  ]
}